TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomes
Journal article published in 2024 by
Y. Loriot 
,
D. P. Petrylak,
A. Rezazadeh Kalebasty,
A. Fléchon,
R. K. Jain,
S. Gupta,
M. Bupathi,
P. Beuzeboc,
P. Palmbos ,
A. V. Balar ,
C. E. Kyriakopoulos,
D. Pouessel,
C. N. Sternberg,
J. Tonelli,
M. Sierecki
and other authors.
,
D. P. Petrylak,
A. Rezazadeh Kalebasty,
A. Fléchon,
R. K. Jain,
S. Gupta,
M. Bupathi,
P. Beuzeboc,
P. Palmbos ,
A. V. Balar ,
C. E. Kyriakopoulos,
D. Pouessel,
C. N. Sternberg,
J. Tonelli,
M. Sierecki
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 